A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese

Clinical trial NCT07411560 · RECRUITING

Trial details

NCT number: NCT07411560
Sponsor: Novo Nordisk A/S
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight Obese

Start date: 2026-02-09
Primary completion: 2027-01-26
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.